Over 90% of European laryngologists and phoniatricians surveyed would prescribe absolute voice rest after removing a vocal fold polyp (Rihkanen and Geneid, European Archives of Oto-Rhino-Laryngology 2019), yet a 2026 meta-analysis of six randomized trials with 186 participants found no significant difference between short and long rest (Salman et al., Journal of Voice 2026). In the largest US survey, 51.4% of responding otolaryngologists favored complete voice rest and 7 days was the most common duration (Behrman and Sulica, The Laryngoscope 2003). Patients rarely deliver that silence: overall compliance with prescribed voice rest was 34.5% in a two-center cohort (Rousseau et al., Otolaryngology-Head and Neck Surgery 2011), and in March 2026 a Dutch national guideline issued a strong recommendation against routine voice rest after microlaryngeal surgery. Our vocal fold nodules in teachers and singers statistics covers who develops benign lesions; this roundup covers what happens after the surgeon removes them. We aggregated data from The Laryngoscope, Journal of Voice, European Archives of Oto-Rhino-Laryngology, Annals of Otology, Rhinology & Laryngology, the Swedish National Register for Phonosurgery, ClinicalTrials.gov, and the Dutch Cluster Laryngologie guideline.
TL;DR
- 51.4% of 1,208 responding US otolaryngologists favored complete voice rest, and 15% favored no voice rest at all (Behrman and Sulica, The Laryngoscope 2003).
- A majority of US laryngologists prescribe 7 days of complete rest for nodules, cysts, polyps and Reinke’s edema (Joshi and Johns, The Laryngoscope 2018).
- Mean absolute voice rest recommended in Europe: 4 days among phoniatricians, 5 days among laryngologists (Rihkanen and Geneid, European Archives of Oto-Rhino-Laryngology 2019).
- 3 days of rest beat 7 days on jitter, shimmer and VHI-10 at 1 month in a 31-patient RCT (Kaneko et al., Journal of Voice 2017).
- Six RCTs with 186 participants showed no significant difference between short and long voice rest (Salman et al., Journal of Voice 2026).
- Pooled VHI-10 change, no rest vs absolute rest: MD -0.87 (95% CI -2.51 to 0.77; P = 0.27) across 355 patients (Lam et al., Journal of Voice 2024).
- The Netherlands now strongly recommends against routine voice rest after microlaryngeal surgery (Richtlijnendatabase, Stemklachten guideline 2026).
- Overall compliance with prescribed voice rest: 34.5% (Rousseau et al., Otolaryngology-Head and Neck Surgery 2011).
- Patient self-reports ran 79-83 standardized units below dosimeter-measured voice use (Rubino et al., The Laryngoscope 2026).
- Average benign lesion recurrence after surgery: 13.0% across 1,085 patients (Gocal et al., Journal of Voice 2025).
- Singers returned to performance an average of 65.0 days after microlaryngoscopy (Rives et al., The Laryngoscope 2024).
1. How Surgeons Prescribe Voice Rest: US and UK Surveys
The headline survey numbers do not add up to 100%, and that is the point. 51.4% of respondents favored complete voice rest while 62.3% favored relative rest, because respondents could favor both types, and 15% favored neither. That is not a consensus protocol: it is a menu, and the only shared anchor is the 7-day mark.
The more recent laryngologist survey shows lesion type, more than surgical technique, drives the prescription: 7 days of complete rest for nodules, cysts, polyps and Reinke’s edema, but only 1 to 4 days for leukoplakia and papilloma, with relative rest typically running over 8 days (Joshi and Johns, The Laryngoscope 2018). The large US dataset is old: most recent available data: Behrman and Sulica, The Laryngoscope 2003.
| Metric | Value | Source |
|---|---|---|
| AAO-HNS members surveyed and response | 7,321 mailed; 16.5% responded (1,208) | Behrman and Sulica, The Laryngoscope 2003 |
| Respondents favoring complete voice rest | 51.4% (620) | Behrman and Sulica, The Laryngoscope 2003 |
| Respondents favoring relative voice rest | 62.3% (753) | Behrman and Sulica, The Laryngoscope 2003 |
| Respondents who do not favor any voice rest | 15% | Behrman and Sulica, The Laryngoscope 2003 |
| Most common duration, complete or relative rest | 7 days | Behrman and Sulica, The Laryngoscope 2003 |
| Majority complete-rest duration for nodules, cysts, polyps, Reinke’s edema | 7 days | Joshi and Johns, The Laryngoscope 2018 |
| Majority complete-rest duration for leukoplakia and papilloma | 1 to 4 days | Joshi and Johns, The Laryngoscope 2018 |
| UK respondents defining complete voice rest as no sound production at all | 86.5% | Coombs et al., Journal of Laryngology & Otology 2013 |
Context: the UK survey also found that surgeons with less than 10 years of experience were more likely to recommend fewer days of rest (Coombs et al., Journal of Laryngology & Otology 2013), which hints that shorter protocols spread through training rather than through guideline change. The Joshi and Johns abstract does not report a respondent count.
2. European Practice and What Patients Actually Did
European surgeons prescribe shorter absolute rest than the US 7-day norm, but nearly all of them still prescribe it. 42% of phoniatrician responses recommended absolute rest longer than 3 days, the threshold beyond which the authors found no supporting evidence, and the recommended range stretched from 0 to 14 days for the same two standardized case vignettes (Rihkanen and Geneid, European Archives of Oto-Rhino-Laryngology 2019).
Registry data show what patients actually did. In Sweden, almost a quarter of polyp patients simply spoke normally after surgery, which turns the national register into an accidental natural experiment (section 4 shows how their outcomes compared) (Björck et al., Laryngoscope Investigative Otolaryngology 2022).
| Metric | Value | Source |
|---|---|---|
| Respondents who would recommend absolute rest (polyp and Reinke’s edema cases) | Over 90% | Rihkanen and Geneid, European Archives of Oto-Rhino-Laryngology 2019 |
| Respondents who found absolute rest unnecessary | 8% (UEP), 7% (ELS) | Rihkanen and Geneid, European Archives of Oto-Rhino-Laryngology 2019 |
| Mean absolute rest, Union of European Phoniatricians 2018 vs European Laryngological Society 2012 | 4 days (range 0-10) vs 5 days (range 0-14) | Rihkanen and Geneid, European Archives of Oto-Rhino-Laryngology 2019 |
| UEP responses recommending absolute rest over 3 days | 42% | Rihkanen and Geneid, European Archives of Oto-Rhino-Laryngology 2019 |
| Polyp patients in Swedish register reporting postoperative voice rest, 2008-2018 | 588 of 828 operated (71%) | Björck et al., Laryngoscope Investigative Otolaryngology 2022 |
| Swedish polyp patients reporting complete silence for a few days | 289 of 588 | Björck et al., Laryngoscope Investigative Otolaryngology 2022 |
| Swedish polyp patients who spoke only single words for a few days | 162 of 588 | Björck et al., Laryngoscope Investigative Otolaryngology 2022 |
| Swedish polyp patients who spoke normally | 137 of 588 | Björck et al., Laryngoscope Investigative Otolaryngology 2022 |
Context: the European surveys had response rates of 23% (2018) and 29% (2012), so they describe engaged specialists, not every practitioner. The Swedish register covers 2008 to 2018 and does not record how many days the rest lasted. Most recent available data: Union of European Phoniatricians survey, 2018 (published 2019).
3. Duration Trials: 3 Days vs 7 Days and Beyond
Every randomized duration trial is small, and the direction of the evidence is largely consistent: longer rest does not buy better voices. In the 31-patient Kaneko trial, the 3-day group beat the 7-day group on jitter, shimmer and VHI-10 at 1 month, and on mucosal wave amplitude at 1, 3 and 6 months (Kaneko et al., Journal of Voice 2017). The single trial that favored longer rest found an advantage on one metric, maximum phonation time.
The attrition numbers matter as much as the outcomes. Only 34 of 65 recruited patients fully complied with the protocol in a 2024 3-day vs 7-day trial (Voloch et al., The Laryngoscope 2024), and one US 3-day vs 7-day trial was terminated after 17 enrollments (ClinicalTrials.gov, NCT02634957). Running a silence trial is hard because silence itself is hard.
| Metric | Value | Source |
|---|---|---|
| Patients analyzed, 3-day vs 7-day absolute rest RCT | 31 (16 vs 15) | Kaneko et al., Journal of Voice 2017 |
| Measures significantly better in 3-day group at 1 month | Jitter, shimmer, VHI-10 | Kaneko et al., Journal of Voice 2017 |
| Normalized mucosal wave amplitude advantage, 3-day group | Significant at 1, 3 and 6 months | Kaneko et al., Journal of Voice 2017 |
| 5-day vs 10-day strict rest RCT | 31 randomized (16 vs 15); 10 days better only on maximum phonation time | Kiagiadaki et al., Annals of Otology, Rhinology & Laryngology 2015 |
| Patients fully complying in 7-day vs 3-day RCT | 34 of 65 recruited; 7 days showed no greater benefit | Voloch et al., The Laryngoscope 2024 |
| 2-day vs 5-day rest RCT, follow-up completion | 35 of 50 subjects | Raju et al., Journal of Voice 2024 |
| University of Pittsburgh 3-day vs 7-day trial | Terminated, 17 enrolled | ClinicalTrials.gov NCT02634957 |
| Optimal rest by injury depth, rabbit phonomicrosurgery model | 1 day (superficial lamina propria); 3 days (mid-deep injury) | Lan et al., World Journal of Otorhinolaryngology-Head and Neck Surgery 2026 |
Context: the Kiagiadaki results were labeled preliminary, and the rabbit data are animal findings that may not transfer to human wound healing. Most recent available randomized data on 3 vs 7 days: Voloch et al., 2024.
4. Rest vs No Rest, Absolute vs Relative
When trials drop voice rest entirely, outcomes barely move. A 30-patient RCT comparing 7 days of absolute rest with no rest after laser resection found no significant benefit to voice rest on postoperative voice outcomes (Dhaliwal et al., The Laryngoscope 2020), and a 167-patient cohort reached the same conclusion on VHI-10 and GRBAS (Cohen et al., European Archives of Oto-Rhino-Laryngology 2022).
The Swedish register adds scale. Patients who spoke normally after polyp surgery were, if anything, the most satisfied group: 126 of 137 (92.0%), against 257 of 289 complete-silence patients (257 / 289 = 88.9%) and 136 of 162 single-word patients (136 / 162 = 84.0%). The satisfaction gap was not statistically significant (see the relative risk row below), which is exactly the finding: silence did not earn a better result. Readers comparing jitter and shimmer across these trials can find how those acoustic measures behave in our acoustic voice analysis and dysphonia statistics.
| Metric | Value | Source |
|---|---|---|
| 7 days absolute rest vs no rest after laser resection, RCT size | 30 patients, 15 per arm | Dhaliwal et al., The Laryngoscope 2020 |
| Voice rest vs no restriction cohort | 167 patients (92 vs 75) | Cohen et al., European Archives of Oto-Rhino-Laryngology 2022 |
| VHI-10 and GRBAS improvement, rest vs none | P = 0.5303 and P = 0.1457 (not significant) | Cohen et al., European Archives of Oto-Rhino-Laryngology 2022 |
| 7 days absolute vs relative rest, blinded RCT | 20 patients; no significant difference in short- or long-term recovery | Whitling et al., Logopedics Phoniatrics Vocology 2018 |
| 7-day complete rest vs 3 days complete plus 4 days controlled use | 25 randomized (13 vs 12); no significant group effect | Fan et al., The Laryngoscope 2024 |
| Mean VHI at 1 month, complete rest vs combined regimen | 36.78 vs 39.85 (from 72 and 61.25 preoperatively) | Fan et al., The Laryngoscope 2024 |
| Swedish patients satisfied with voice, spoke normally | 92.0% (126 of 137) | Björck et al., Laryngoscope Investigative Otolaryngology 2022 |
| Risk of dissatisfaction, total rest or single words vs normal speech | RR 1.72 (95% CI 0.97-3.35, P = .083) | Björck et al., Laryngoscope Investigative Otolaryngology 2022 |
Context: in the Whitling trial the absolute-rest group phonated significantly less during the first week but was not silent, and reported more difficulty complying (Whitling et al., Logopedics Phoniatrics Vocology 2018). Swedish register patients were not randomized, so age and preoperative severity differ between groups.
5. What the Pooled Evidence and Guidelines Say
Three of the four systematic reviews published between 2023 and 2026 reach the same verdict from different inclusion criteria: no measurable payoff from longer or stricter rest. The 2023 Laryngoscope meta-analysis even found short rest significantly better on VHI for benign lesions (MD -14.45; 95% CI -26.19 to -2.72; p = 0.02) and for cold-instrument surgery (Chi et al., The Laryngoscope 2023).
Guidelines have started to follow. The Dutch voice complaints guideline, validated on 12 March 2026, gives a strong recommendation against routine voice rest after microlaryngeal surgery, reserving it for lesions where vocal fold contact plays a causal role, such as contact granuloma (Richtlijnendatabase, Stemklachten guideline 2026). It also states that the belief that at least 3 days of rest are needed for optimal healing is not supported by the evidence.
| Metric | Value | Source |
|---|---|---|
| RCTs and patients in short (<7 days) vs long rest meta-analysis | 4 RCTs, 112 patients | Chi et al., The Laryngoscope 2023 |
| VHI, short vs long rest, all trials | MD -7.01 (95% CI -16.12 to 2.09; p = 0.13) | Chi et al., The Laryngoscope 2023 |
| VHI, short vs long rest, cold-instrument subgroup | MD -15.98 (95% CI -28.52 to -3.44; p = 0.01) | Chi et al., The Laryngoscope 2023 |
| Studies meeting inclusion, voice rest outcome review | 9 of 255 articles | Lam et al., Journal of Voice 2024 |
| VHI-10 change, no rest vs absolute rest (355 patients) | MD -0.87 (95% CI -2.51 to 0.77; P = 0.27) | Lam et al., Journal of Voice 2024 |
| Short vs long rest, pooled RCTs | 6 RCTs, 186 participants; no significant difference | Salman et al., Journal of Voice 2026 |
| Studies meeting inclusion, efficacy and compliance review | 5 of 275 articles; rest ranged 3 to 7 days | Aldaihani et al., European Archives of Oto-Rhino-Laryngology 2025 |
| Fundamental frequency at 12 weeks, no rest vs absolute rest | MD 33.69 Hz lower (95% CI -53.57 to -13.81) | Richtlijnendatabase, Stemklachten guideline 2026 |
Context: the Dutch panel rated overall certainty of evidence as very low, and said the fundamental frequency difference is hard to interpret clinically. The one dissenting signal is the 2025 review of 5 studies, which reported significant improvements in VAS and VHI scores with voice rest compared to no rest but gave no effect sizes. The newest pooled estimate, registered on PROSPERO, is Salman et al., Journal of Voice 2026.
6. Adherence: What Patients Report vs What Dosimeters Record
Every duration debate assumes patients follow the prescription. Many do not. Overall compliance with prescribed voice rest was 34.5%, and 46.4% of patients were unable to work while on rest (Rousseau et al., Otolaryngology-Head and Neck Surgery 2011). Most recent available data on quality-of-life burden: Rousseau et al., 2011.
Self-report is also unreliable as a measurement tool. In a 23-patient dosimeter study, patients’ own estimates ran 79-83 standardized units lower than the instrumental data, and voice use did not differ between complete and relative rest groups (Rubino et al., The Laryngoscope 2026). Voice therapy counseling appears to help: talking fell by 63% in a therapy group and 65% in a counseling group versus 35% in an evaluation-only group after office procedures (King et al., American Journal of Speech-Language Pathology 2021). Access to that counseling depends on clinician capacity, covered in our speech-language pathologist workforce and caseload statistics.
| Metric | Value | Source |
|---|---|---|
| Overall compliance with prescribed voice rest (84 patients) | 34.5% | Rousseau et al., Otolaryngology-Head and Neck Surgery 2011 |
| Compliance, postoperative vs non-postoperative patients | 42.4% vs 16.0% (P = .04) | Rousseau et al., Otolaryngology-Head and Neck Surgery 2011 |
| Compliance with absolute voice rest, 2-day vs 5-day RCT | 43% | Raju et al., Journal of Voice 2024 |
| Compliance with 3 days of complete voice rest, Japanese cohort | 70.9% | Mato et al., Japan Journal of Logopedics and Phoniatrics 2020 |
| Office-procedure patients who never used their voice during rest | 39.5% | King et al., American Journal of Speech-Language Pathology 2021 |
| Dosimeter-measured phonation, complete vs relative rest | 1.65% vs 4.59% of each hour | Dhaliwal et al. 2020, as reported in Rubino et al., The Laryngoscope 2026 |
| Self-reported phonation, complete vs relative rest | 1.30 vs 10.30 min per hour | Dhaliwal et al. 2020, as reported in Rubino et al., The Laryngoscope 2026 |
| Estimated average daily voice use during 7-day postoperative rest | 57.19 minutes | Rubino et al., Journal of Voice 2025 |
Context: the King cohort covered office-based procedures with 1-3 days of absolute rest, not microlaryngeal surgery under general anesthesia, and 84% of its participants reported completing rest for at least as long as recommended. The Rubino 2025 study also found men used their voices an estimated 81.98 minutes more per day than women during rest.
7. Recurrence and Return to Voice Use
Recurrence data reframe the voice rest question: what happens after the first week matters more than the first week itself. Studies with adjunctive therapies reported a 7.14% recurrence rate versus 24.44% in studies without them (Gocal et al., Journal of Voice 2025), and a 2026 retrospective cohort put overall recurrence at 17.0% after initial resolution (Vlase et al., Medicina 2026).
Return-to-voice timelines run in weeks, not days. Singers averaged about two months to get back on stage (Rives et al., The Laryngoscope 2024), European specialists recommended a mean of 14 days of sick leave for a teacher with a polyp, and Swedish clinics put most patients on sick leave for 1 week. A typical staged protocol in the Japanese cohort ran complete rest for days 1-3, relative rest for days 4-7, and daily conversation for days 8-14 (Mato et al., Japan Journal of Logopedics and Phoniatrics 2020). For deeper structural lesions, see our sulcus vocalis phonosurgery voice outcome statistics.
| Metric | Value | Source |
|---|---|---|
| Average benign lesion recurrence after surgery (11 studies, 1,085 patients) | 13.0% | Gocal et al., Journal of Voice 2025 |
| Recurrence, studies with vs without adjunctive therapies | 7.14% vs 24.44% | Gocal et al., Journal of Voice 2025 |
| Recurrence, cold instruments vs CO2 laser | 24.1% (7/29) vs 11.1% (3/27); p = 0.299 | Vlase et al., Medicina 2026 |
| Nodule recurrence, primary surgery vs delayed surgery vs therapy alone | 26.5% vs 8.0% vs 4.2% | Kim et al., European Archives of Oto-Rhino-Laryngology 2026 |
| Vocal fold cyst recurrence after endoscopic marsupialization (107 patients) | 4.7% | Motohashi et al., Cureus 2025 |
| Average time to return to vocal performance, singers (69 patients) | 65.0 ± 29.8 days | Rives et al., The Laryngoscope 2024 |
| Singers needing oral steroids for edema within 6 months of return | 11.6% (8 of 69) | Rives et al., The Laryngoscope 2024 |
| Mean recommended sick leave, polyp and Reinke’s edema cases (UEP) | 14 days (range 1-35) | Rihkanen and Geneid, European Archives of Oto-Rhino-Laryngology 2019 |
Context: the cold-instrument vs laser comparison was described by its authors as underpowered and unadjusted, and the Kim cohort’s primary surgery patients had worse baseline measures. In the Rives series, 82.6% of singers underwent voice therapy and only one had a pseudocyst recurrence.
Summary: Voice Rest After Microlaryngeal Surgery by the Numbers
| Metric | Value | Source |
|---|---|---|
| US otolaryngologists favoring complete voice rest | 51.4% | Behrman and Sulica, The Laryngoscope 2003 |
| 7 days absolute vs relative rest, blinded RCT | No significant difference in recovery (20 patients) | Whitling et al., Logopedics Phoniatrics Vocology 2018 |
| US laryngologist majority, complete rest for nodules, cysts, polyps | 7 days | Joshi and Johns, The Laryngoscope 2018 |
| European specialists recommending absolute rest | Over 90% | Rihkanen and Geneid, European Archives of Oto-Rhino-Laryngology 2019 |
| Swedish polyp patients who spoke normally after surgery | 137 of 588 | Björck et al., Laryngoscope Investigative Otolaryngology 2022 |
| 3-day vs 7-day RCT, measures better with 3 days at 1 month | Jitter, shimmer, VHI-10 | Kaneko et al., Journal of Voice 2017 |
| Full protocol compliance, 7-day vs 3-day RCT | 34 of 65 recruited | Voloch et al., The Laryngoscope 2024 |
| 7 days absolute rest vs no rest, RCT result | No significant benefit (30 patients) | Dhaliwal et al., The Laryngoscope 2020 |
| Voice rest vs no restriction cohort | 167 patients; no significant VHI-10 or GRBAS difference | Cohen et al., European Archives of Oto-Rhino-Laryngology 2022 |
| VHI, short vs long rest, benign lesions | MD -14.45 (p = 0.02) | Chi et al., The Laryngoscope 2023 |
| VHI-10 change, no rest vs absolute rest | MD -0.87 (P = 0.27), 355 patients | Lam et al., Journal of Voice 2024 |
| Short vs long rest, pooled RCTs | 6 RCTs, 186 participants, no significant difference | Salman et al., Journal of Voice 2026 |
| Dutch guideline on routine voice rest | Strong recommendation against | Richtlijnendatabase, Stemklachten guideline 2026 |
| Overall compliance with prescribed voice rest | 34.5% | Rousseau et al., Otolaryngology-Head and Neck Surgery 2011 |
| Compliance with absolute rest in an RCT | 43% | Raju et al., Journal of Voice 2024 |
| Self-report vs dosimeter gap | 79-83 standardized units lower | Rubino et al., The Laryngoscope 2026 |
| Average benign lesion recurrence | 13.0% | Gocal et al., Journal of Voice 2025 |
| Recurrence with vs without adjunctive therapies | 7.14% vs 24.44% | Gocal et al., Journal of Voice 2025 |
| Singers’ average time to return to performance | 65.0 ± 29.8 days | Rives et al., The Laryngoscope 2024 |
Methodology and Sources
We ran targeted searches across surgeon surveys, randomized trials, systematic reviews, registries, guidelines and trial registries, then read each abstract or full text through publisher pages, PubMed Central and the Europe PMC API. Every figure above comes from a document read for this roundup; derived percentages show their arithmetic.
- Behrman A, Sulica L. Voice rest after microlaryngoscopy: current opinion and practice. The Laryngoscope 2003
- Joshi A, Johns MM. Current practices for voice rest recommendations after phonomicrosurgery. The Laryngoscope 2018
- Coombs AC et al. Voice rest after vocal fold surgery: current practice and evidence. Journal of Laryngology & Otology 2013 (DOI 10.1017/s0022215113001485)
- Rihkanen H, Geneid A. Voice rest and sick leave after phonosurgical procedures. European Archives of Oto-Rhino-Laryngology 2019
- Björck G et al. Voice rest after vocal fold polyp surgery: a Swedish register study of 588 patients. Laryngoscope Investigative Otolaryngology 2022
- Kaneko M et al. Optimal duration for voice rest after vocal fold surgery: randomized controlled clinical study. Journal of Voice 2017
- Kiagiadaki D et al. The effect of voice rest on the outcome of phonosurgery for benign laryngeal lesions. Annals of Otology, Rhinology & Laryngology 2015 (DOI 10.1177/0003489414560583)
- Voloch L et al. Seven days of voice rest post-phonosurgery is not better than 3 days. The Laryngoscope 2024
- Raju T et al. Early initiation of voice therapy after microlaryngeal surgery: a randomized control study. Journal of Voice 2024 (DOI 10.1016/j.jvoice.2021.12.004)
- ClinicalTrials.gov NCT02634957, Impact of Duration of Absolute Voice Rest on Voice Outcome After Phonomicrosurgery (University of Pittsburgh)
- Lan LL et al. Surgical depth and postoperative voice rest duration in a rabbit phonomicrosurgery model. World Journal of Otorhinolaryngology-Head and Neck Surgery 2026 (DOI 10.1002/wjo2.70106)
- Dhaliwal SS et al. Role of voice rest following laser resection of vocal fold lesions: a randomized controlled trial. The Laryngoscope 2020
- Cohen JT et al. The role of voice rest after micro-laryngeal surgery for benign vocal fold lesions. European Archives of Oto-Rhino-Laryngology 2022
- Whitling S, Lyberg Åhlander V, Rydell R. Absolute or relative voice rest after phonosurgery: a blind randomized prospective clinical trial. Logopedics Phoniatrics Vocology 2018
- Fan RS et al. Clinical voice outcomes for two voice rest protocols after phonomicrosurgery. The Laryngoscope 2024
- Chi HW et al. Effects of different voice rest on vocal function after microlaryngeal surgery: a systematic review and meta-analysis. The Laryngoscope 2023
- Lam D et al. Is postoperative voice rest unnecessary? A systematic review and meta-analysis. Journal of Voice 2024
- Salman B et al. Short duration vs long duration voice rest for vocal recovery post-phonosurgery: a systematic review and meta-analysis of RCTs. Journal of Voice 2026
- Aldaihani A et al. Voice rest after vocal fold surgery: a systematic review of efficacy, duration, and compliance. European Archives of Oto-Rhino-Laryngology 2025 (DOI 10.1007/s00405-025-09470-1)
- Richtlijnendatabase (Cluster Laryngologie, NVKNO, NVLF). Stemklachten guideline, module Stemrust na stembandoperatie, 2026
- Rousseau B et al. Compliance and quality of life in patients on prescribed voice rest. Otolaryngology-Head and Neck Surgery 2011
- Rubino M et al. Patient report versus instrumental measurement of voice use during postsurgical voice rest. The Laryngoscope 2026
- Rubino M et al. Early insights into the role of personality in adherence to voice rest after phonomicrosurgery. Journal of Voice 2025
- King RE et al. Role of voice therapy in adherence to voice rest after office-based vocal fold procedures. American Journal of Speech-Language Pathology 2021
- Mato S et al. Effectiveness of complete voice rest followed by relative voice rest using confidential voice after phonomicrosurgery. Japan Journal of Logopedics and Phoniatrics 2020
- Gocal WA et al. Systematic review of recurrence rates of benign vocal fold lesions following surgery. Journal of Voice 2025
- Vlase A et al. Recurrence of benign vocal fold lesions: risk factors and cold-instrument vs CO2 laser surgery. Medicina 2026
- Kim JH et al. Predictors of poor response to voice therapy in adult vocal fold nodules. European Archives of Oto-Rhino-Laryngology 2026
- Motohashi R et al. Endoscopic marsupialization of vocal fold cyst under topical anesthesia. Cureus 2025 (DOI 10.7759/cureus.85949)
- Rives H et al. Return to vocal performance following microlaryngoscopy in singers. The Laryngoscope 2024
- Data watch: the largest US surgeon survey dates from 2003 (16.5% response), and the 2018 laryngologist survey abstract reports no respondent count, so there is no current, sized US baseline. Gocal et al. and Raju et al. carry 2025 and 2024 issue dates but were first published online in 2022 and 2021. The Voloch 2024 abstract lists 19 males and 20 females but 17 plus 16 patients in its two arms and 34 compliers, so its group counts are inconsistent. The Rubino 2026 abstract reports F = 4.34 (daily) while its Results section reports F = 9.15, both significant. The 2023, 2024, 2025 and 2026 reviews draw on overlapping small trials, so they are not independent confirmations of one another. The Dutch guideline excluded the Lam 2024 review for missing outcome data. Recurrence figures mix lesion types, techniques and follow-up lengths, and none of the recurrence studies isolates voice rest as a variable.
Last updated: October 18, 2026. We update this roundup quarterly, and the next refresh is expected when the Voice Rest Versus Hypofunctional Whispering After Phonosurgery trial (ClinicalTrials.gov NCT07704125, completed May 2026) publishes its results.